Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization against potential biological warfare agents.

T J Cieslak1, G W Christopher, M G Kortepeter

  • 1Operational Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, 21702 USA. Ted.Cieslak@amedd.army.mil

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|July 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discernment between deliberate and natural infectious disease outbreaks.

Epidemiology and infection·2006
Same author

Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.

Vaccine·2006
Same author

Lessons learned.

Disaster management & response : DMR : an official publication of the Emergency Nurses Association·2003
Same author

Reducing the bioweapons threat: international collaboration efforts.

Public health reports (Washington, D.C. : 1974)·2002
Same author

Department of Defense West Nile virus surveillance.

Annals of the New York Academy of Sciences·2002
Same author

Medical consequences of biological warfare: the Ten Commandments of management.

Military medicine·2002
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Sepsis Diagnostic Excellence and its Association with Mortality in Adults with Potential Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Biological threats from terrorism are a growing concern. This review examines the development of vaccines for 10 credible biological threat agents, crucial for pre- and post-exposure protection.

Area of Science:

  • Biodefense
  • Vaccinology
  • Public Health Security

Background:

  • Intentional release of biological agents by terrorists is an increasing threat.
  • Law enforcement, military, public health, and clinicians are increasingly aware of this risk.
  • Immunization is a key component of military pre-exposure defense against biological threats.

Purpose of the Study:

  • To review vaccine development against 10 credible biological threat agents.
  • To highlight the role of vaccines in responding to bioterrorism.
  • To inform strategies for civilian protection against biological attacks.

Main Methods:

  • Literature review of vaccine development.
  • Focus on 10 high-threat biological agents.
  • Analysis of vaccine applications in pre- and post-exposure prophylaxis.

Related Experiment Videos

Main Results:

  • Vaccines are essential for both preventing and responding to bioterrorism.
  • Development efforts are underway for vaccines against critical biological threats.
  • Vaccines offer a viable strategy for protecting civilian populations.

Conclusions:

  • Vaccine development is a critical aspect of biodefense.
  • Proactive immunization strategies are necessary to counter biological threats.
  • Preparedness requires robust vaccine research and deployment capabilities.